<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vande Griend, Joseph P.</style></author><author><style face="normal" font="default" size="100%">Saseen, Joseph J.</style></author><author><style face="normal" font="default" size="100%">Bislip, Debra</style></author><author><style face="normal" font="default" size="100%">Emsermann, Caroline</style></author><author><style face="normal" font="default" size="100%">Conry, Colleen</style></author><author><style face="normal" font="default" size="100%">Pace, Wilson D.</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Prioritization of Patients for Comprehensive Medication Review By a Clinical Pharmacist in Family Medicine</style></title><secondary-title><style face="normal" font="default" size="100%">The Journal of the American Board of Family
                Medicine</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-05-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">418-424</style></pages><doi><style  face="normal" font="default" size="100%">10.3122/jabfm.2015.03.140303</style></doi><volume><style face="normal" font="default" size="100%">28</style></volume><issue><style face="normal" font="default" size="100%">3</style></issue><abstract><style  face="normal" font="default" size="100%">Background: This pilot study describes and evaluates the clinical pharmacy priority (CP2) score. We hypothesize that patients with high CP2 scores are more likely to receive a medication recommendation after comprehensive medication review (CMR) than patients with lower scores. Prioritization of patients for CMR by a clinical pharmacist in family medicine could enhance the provision of interprofessional care within the patient-centered medical home. Methods: The CP2 score was developed collaboratively by the research team and is derived from 11 patient-specific factors extracted from the electronic health record. To evaluate the utility of the score, CMR was performed prospectively by a clinical pharmacist for patients with appointments between October 1 and December 31, 2012, at 2 University of Colorado family medicine clinics. Results: CMR was performed for 1107 patient appointments. Of these, 101 were identified as having received a medication recommendation from the clinical pharmacist. For patients with a CP2 score of 0 to 2, 2 of 588 charts (0.3%) reviewed received a recommendation (level 1). The proportion increased to 37 of 358 (10.3%) for scores of 3 to 7 (level 2), 40 of 119 (33.6%) for scores of 8 to 10 (level 3), and 22 of 42 (52.4%) for scores of ≥11 (level 4). Compared with CP2 scores in level 1, patient appointments were more likely to receive a medication recommendation after CMR in level 2 (relative risk [RR], 30.4; 95% confidence interval [CI], 7.4–125.3), in level 3 (RR, 98.8; 95% CI, 24.2–403.3), and in level 4 (RR, 154; 95% CI, 37.5–632.8). Conclusions: Patients with higher CP2 scores were more likely to receive a medication recommendation after CMR by a clinical pharmacist than patients with lower scores. The CP2 score could be used by clinical pharmacists in family medicine to enhance the efficient and effective delivery of interprofessional care.</style></abstract></record></records></xml>